Network marketing (also called direct sales or relationship marketing) is a legitimate, legally regulated business model where independent partners sell real products directly to real customers and earn commission both on their own sales and on the sales generated by the team they build. Think of it as word-of-mouth commerce with a built-in pay structure — and when the products are genuinely evidence-based, it becomes one of the most powerful distribution models available.

Here's why it stands apart:

It scales in a way your effort alone never can. Unlike a traditional job where income is fixed to the hours you put in, network marketing operates on a leverage principle: your initial effort builds a team, and that team continues generating income whether you're in clinic, on holiday, or sleeping. The equation shifts from effort = outcome to effort × team = exponential outcome. That's not hype — it's basic mathematics.

It's nothing like running an e-commerce store or dropshipping operation. E-commerce requires constant investment in paid advertising, stock management, fulfilment logistics, returns, and platform fees. Dropshipping margins are razor-thin and you're entirely at the mercy of third-party suppliers. Network marketing, by contrast, has no stock to hold, no warehouse, no postage runs. The infrastructure — fulfilment, payment processing, customer service — is all handled by the parent company. You focus on people, not parcels.

It's genuinely built on helping others reach their goals. The model only works if the people around you succeed. Unlike a salaried structure where your colleague's promotion is your loss, here your colleague's win is directly your win. That creates a completely different culture — one of mentorship, knowledge-sharing, and mutual investment. You grow when they grow. Full stop.

The products have to be real — and worth talking about. This is where I'm particularly selective. I wouldn't put my name, my medical reputation, or my patients near anything I hadn't scrutinised clinically. Precision diagnostics, biomarker-led supplementation, measurable outcomes — these are things I can stand behind in any consulting room. The conversation sells itself because the science does the heavy lifting.

The entry barrier is low; the ceiling is uncapped. No premises, no staff costs, no significant capital outlay. You can start part-time alongside existing work and scale at your own pace. Whether you want a meaningful side income or a full business pivot, the model accommodates both.

The short version? Network marketing done properly — with credible products, transparent compensation, and a genuine commitment to customer outcomes — is one of the most democratised, scalable, and ethically sound business models available. It's not selling hope. It's building something that actually works, with people who actually care.

Let's address the elephant in the room — because if you're medically trained or scientifically minded, you should be asking exactly this question.

Zinzino operates as a direct sales company, a model that has, frankly, been tarnished by association with illegitimate pyramid schemes. So let's be clear about the distinction, because it's not complicated.

A pyramid scheme generates revenue primarily through recruiting new members, typically via an upfront fee. There is little to no genuine product, no real customer base, and no sustainable foundation. It collapses — inevitably — because it has nothing of substance underneath it.

Zinzino is the opposite of that. Revenue is driven by customer subscriptions to scientifically validated products. Compensation is tied directly to product sales, not recruitment fees. The customer base is real, the products are consumable and repeat-purchased because they work, and the science is peer-reviewed and independently validated.

I wouldn't be here if that weren't the case. After 30 years in clinical medicine, my professional reputation is not something I trade lightly. I scrutinise the evidence the same way I would any clinical intervention — and Zinzino's test-based, biomarker-led approach stands up to that scrutiny.

There's also a structural safeguard worth noting: Zinzino is publicly traded on the Nasdaq First North exchange. That means audited accounts, regulatory compliance, and transparency obligations that no backroom pyramid scheme could survive. You can look them up. I'd encourage you to.

Bottom line — this is a legitimate, regulated, evidence-based business. I wouldn't have built my practice around it otherwise.

Short answer — yes. A substantial, rapidly growing, and scientifically validated one.

The global personalised nutrition market was valued at approximately $15 billion in 2025 and is projected to exceed $60 billion by 2034. That isn't niche territory. That's a fundamental restructuring of how people approach their health.

But here's what the market data doesn't tell you — and what 30 years in clinical practice does. This shift isn't driven by marketing. It's driven by a growing public frustration with generic approaches that don't deliver measurable results. People are tired of being told to take a multivitamin and come back in six months. They want to know what's actually happening in their body, and they want evidence that what they're doing is working.

That's precisely where test-based nutrition sits — and why it's different from the sea of supplements lining pharmacy shelves. When you can show someone their omega 6:3 ratio before and after a 120-day protocol, the conversation changes entirely. It moves from "I think this might help" to "here is your data, and here is what it means." That's not wellness. That's precision medicine — and clinically, that's where the profession has been heading for years.

The market exists because the need exists. Chronic inflammation, metabolic dysfunction, poor gut health — these are not fringe concerns. They sit at the root of the majority of long-term conditions I've spent my career managing. The difference now is that we have accessible, validated tools to measure them at an individual level, before disease takes hold.

Test-based nutrition isn't a trend. It's where evidence-based healthcare and proactive self-management finally meet.

This was the question I needed answered before I put my name anywhere near this. As a clinician, "scientifically credible" isn't a marketing phrase — it's a threshold. Here's what cleared it for me.

Independent analysis. The BalanceTest uses dried blood spot sampling, processed exclusively by Vitas Analytical Services in Oslo — a world-leading, independent laboratory with no commercial interest in the outcome. That independence matters. The result you receive isn't generated by the company selling you the supplement. That's a meaningful distinction.

A dataset that no competitor can match. With over one million tests processed, Zinzino has built the world's largest database of fatty acid profiles. That scale isn't just impressive — it's scientifically significant. It means population-level insight into nutritional deficiencies, intervention efficacy, and global trends that simply cannot be replicated by smaller operators. When I look at a patient's result, it's benchmarked against a genuinely robust reference population.

The science focuses on ratios, not just levels. The BalanceTest measures two critical biomarkers: the Omega-6:3 ratio and the Omega-3 Index. The Omega-6:3 ratio reflects the inflammatory balance within the body — the Western dietary average sits at around 15:1, significantly pro-inflammatory, against a scientifically recommended target of 3:1 or better. The Omega-3 Index measures the percentage of EPA and DHA in red blood cell membranes and is an established cardiovascular risk marker. Measuring both gives a far more complete picture than either alone.

And critically — the outcomes are measurable. 95% of individuals using BalanceOil+ reach or approach the optimal ratio within 120 days, confirmed by a second test. That's not a testimonial. That's a before-and-after biomarker shift, independently verified. In clinical terms, that's what efficacy looks like.

The short answer to all three is no — but let me be straight with you about what you do need, because I'm not going to dress this up.

On medical background: a clinical or scientific background is genuinely useful here, because it means you can read the evidence, interrogate the data, and speak about inflammation and biomarker testing with authority. But it is not a prerequisite. The products, the testing platform, and the science are accessible to anyone willing to learn. What a medical background gives you is credibility and a head start — not an exclusive entry ticket. Some of the most effective partners in this space come from fitness, nutrition, business, and entrepreneurship backgrounds. The common thread isn't a degree — it's genuine belief in what they're sharing.

On sales experience: this model isn't built on sales technique. It's built on conversation and education. If you can talk about something you genuinely believe in, to people who have a real need for it, you are already most of the way there. The products start a conversation that the data then closes. Nobody is cold-calling strangers or delivering a rehearsed pitch. The approach is educational, not transactional — and that distinction matters enormously, particularly for those of us who find traditional "selling" uncomfortable.

On network size: you don't need a large network to start — you need a relevant one. Ten people who are genuinely interested in their health will take you further than a thousand lukewarm social media followers. Most people begin with their immediate professional and personal circle and expand from there. What Zinzino's global infrastructure and 20+ years of direct sales experience gives you is a proven system, full training, and a team structure that means you are never building this alone. As the saying goes — you work for yourself, but not by yourself.

What I would say you genuinely need is a growth mindset, the willingness to invest time upfront, and enough intellectual curiosity to engage with the science. If you have those three things, the rest is learnable. That's been my experience, and I've watched it replicated across partners from wildly different professional backgrounds.

Two very fair questions — and ones I'd be asking too. Let me answer both directly.

On support: this is something I feel strongly about, because I've seen people join business opportunities and then be left entirely to their own devices with a starter pack and a prayer. That's not how this works — or at least, not how I work.

From day one you'll have a structured onboarding process, a personal 1-2-1 session with me, and access to a team framework that has been built and refined over years of real-world experience. There is training on the products, the science, the business model, and the practical day-to-day of building your partner network. You are not handed a leaflet and wished luck. Think of it as a proper induction — the kind you'd expect starting any credible professional role.

Beyond the initial onboarding, the support is ongoing. Regular team contact, access to resources, mentorship, and a community of people who are genuinely invested in your progress — because, as we've already established, your success directly contributes to theirs. That alignment of interests is what makes the support real rather than performative.

Zinzino also brings 20+ years of direct sales infrastructure behind you — fulfilment, customer service, compliance, and a global platform that no individual could build alone. You leverage all of that from the moment you start.

On investment: there are several entry points, and I'll be transparent about them because I think clarity here is non-negotiable.

At the most accessible end, there is a free option — no product outlay, just your personal website and full team support, with a monthly subscription of £75 that is waived once you have 10 subscription customers. From there, partner kits range from £189 for a basic starter pack, through to £550 for the Health Protocol Kit which includes the core product range, up to £1,039 for the Ultimate Kit — the most comprehensive option, designed for those who want to build this as a primary income. Notably, if you bring in 25 premium customers within 12 months on the Ultimate Kit, your initial investment is refunded in month 13.

None of these figures represent significant capital risk compared to any traditional business start-up. There are no premises, no stock to warehouse, no staff costs, and no ongoing overheads beyond the monthly subscription — which, again, is waived once your customer base reaches a straightforward threshold.

My honest advice? Choose the entry point that reflects your level of commitment and what you can comfortably invest without financial strain. Start where you are, build from there, and let the results inform your next step. That's exactly what I did.